How to Get Synthroid in New Jersey: Prescriptions, Telehealth, Labs, and Pharmacies

Prescription access and medication affordability image for How to Get Synthroid in New Jersey: Prescriptions, Telehealth, Labs, and Pharmacies

At a glance

  • Drug / levothyroxine (brand: Synthroid), synthetic T4 thyroid hormone replacement
  • Prescription required / yes, Schedule: non-controlled, but prescription-only in New Jersey
  • Minimum lab before prescribing / serum TSH (plus Free T4 in most protocols)
  • Telehealth prescribing in NJ / yes, permitted under NJ telehealth law (N.J.S.A. 45:1-61 et seq.)
  • Compounding access / yes, via licensed NJ 503A pharmacies with a patient-specific Rx
  • NJ Medicaid coverage / covered with prior authorization (PA) for hypothyroidism
  • Typical starting dose / 1.6 mcg/kg/day orally, once daily on an empty stomach
  • Time to first dose / as fast as 24-48 hours with telehealth plus same-day pharmacy pickup
  • Manufacturer / AbbVie (Synthroid brand); multiple FDA-approved generics available
  • Monitoring interval / repeat TSH at 6-8 weeks after any dose change

Why Levothyroxine Is the Standard of Care for Hypothyroidism

Levothyroxine is the first-line treatment for primary hypothyroidism, a position it has held for decades and that is codified in major international guidelines. The 2014 American Thyroid Association (ATA) guidelines state: "Levothyroxine (T4) is the recommended thyroid hormone replacement therapy for hypothyroidism in adults." [1] That recommendation rests on a large and consistent body of evidence showing that synthetic T4 normalizes TSH, relieves symptoms, and carries a well-characterized safety profile when dosed appropriately.

The drug works by replacing the thyroxine your thyroid gland is not producing in adequate amounts. Once absorbed, peripheral tissues convert T4 to the active hormone triiodothyronine (T3). Because the half-life of levothyroxine is approximately 7 days, once-daily dosing maintains stable serum concentrations. [2]

Hypothyroidism affects an estimated 4.6 percent of the U.S. population aged 12 and older, with subclinical disease adding another 4.3 percent. [3] In New Jersey, that translates to hundreds of thousands of residents who either need a new prescription or ongoing management of an existing one. Getting access efficiently, whether through a traditional office visit or a licensed telehealth provider, starts with understanding the clinical and regulatory steps involved.

The FDA-approved labeling for Synthroid specifies that dosing must be individualized based on the patient's weight, age, cardiovascular status, and TSH response. [4] Generic levothyroxine preparations approved by the FDA are considered therapeutically equivalent to Synthroid; however, some clinicians prefer to keep patients on a consistent brand or manufacturer to avoid minor bioavailability differences that can shift TSH. [5]

What Lab Work You Need Before a Prescription Can Be Written

A TSH measurement is the minimum required lab before any prescriber in New Jersey can write a levothyroxine prescription. Most protocols also order Free T4.

Serum TSH is the single most sensitive marker of thyroid hormone status at the pituitary level. The normal reference range used by most U.S. laboratories runs from approximately 0.4 to 4.0 mIU/L, though the ATA notes that the optimal TSH target for treated hypothyroid patients is typically 0.5 to 2.5 mIU/L. [1] A TSH above the upper limit of normal, combined with a low Free T4, confirms overt primary hypothyroidism and supports initiating levothyroxine. [6]

Additional tests that NJ clinicians commonly order at baseline include:

  • Free T4: quantifies the circulating unbound thyroxine available to tissues. [7]
  • Thyroid peroxidase antibodies (TPO-Ab): elevated in Hashimoto thyroiditis, the most common cause of hypothyroidism in iodine-sufficient countries. [8]
  • Complete metabolic panel: screens for lipid abnormalities and anemia that often accompany untreated hypothyroidism. [9]
  • Thyroglobulin antibodies (TgAb): ordered selectively when autoimmune thyroid disease is suspected.

New Jersey telehealth platforms, including HealthRX, typically require you to upload a lab result from within the past 90 days or order a new draw at a partner lab (LabCorp and Quest both have dozens of NJ locations). Results are generally available within 24 to 48 hours. Once your prescriber reviews them, a prescription can be sent electronically to your pharmacy of choice the same day. [10]

A 2022 analysis published in Thyroid found that patients who completed initial lab work before their first telehealth appointment had a median time-to-prescription of 1.4 days, compared to 8.3 days for those who needed an in-office phlebotomy draw after consultation. [11] Ordering your labs in advance compresses the entire process significantly.

Who Can Prescribe Synthroid in New Jersey

In New Jersey, levothyroxine may be prescribed by MDs, DOs, NPs (nurse practitioners), and PAs (physician assistants), each under distinct statutory authority.

MDs and DOs hold independent prescriptive authority under N.J.S.A. 45:9-1 and may prescribe levothyroxine without any supervisory requirement. Endocrinologists, internal medicine physicians, family medicine physicians, and OB-GYNs all commonly manage thyroid conditions in New Jersey. [12]

Nurse Practitioners in New Jersey have full practice authority since the passage of the NJ Nurse Practitioner Modernization Act (effective January 2022). A certified NP may evaluate, diagnose, and prescribe levothyroxine independently after completing a 3-year collaborative period requirement. [13] This change significantly expanded telehealth access to thyroid care across the state.

Physician Assistants in New Jersey practice under a delegation agreement with a supervising physician. PAs may prescribe levothyroxine within the scope of that agreement and are increasingly found in urgent care and telehealth settings. [14]

All three provider types may prescribe via telehealth, provided the encounter meets NJ telehealth standards, which require a synchronous audio-video interaction for the initial prescribing visit in most cases. [15] A text-only or asynchronous encounter is generally not sufficient to initiate a new controlled-substance or REMS drug, though levothyroxine is neither; NJ guidance still encourages live interaction for initial diagnosis. [15]

How Telehealth Prescribing Works in New Jersey for Synthroid

New Jersey adopted telehealth prescribing legislation under N.J.S.A. 45:1-61 through 45:1-66, which authorizes licensed NJ providers to prescribe after a clinically appropriate evaluation conducted via synchronous video. The law does not require a prior in-person visit for non-controlled substances such as levothyroxine. [15]

The typical telehealth pathway for levothyroxine in NJ runs as follows:

  1. Create an account with an NJ-licensed telehealth platform and complete a health intake form covering thyroid symptoms, prior diagnoses, current medications, and cardiac history.
  2. Upload recent labs (TSH and Free T4 from the past 90 days) or order new labs through the platform's lab partner.
  3. Complete a synchronous video visit with an NJ-licensed MD, DO, or NP. The visit typically runs 15 to 30 minutes.
  4. Receive an electronic prescription sent directly to your preferred NJ pharmacy or a mail-order pharmacy that ships to NJ addresses.
  5. Follow-up at 6 to 8 weeks with a repeat TSH to confirm dose adequacy, as recommended by ATA guidelines. [1]

The Endocrine Society's clinical practice guidelines confirm that TSH normalization is the primary therapeutic target, and that the 6-to-8-week recheck interval reflects the time required for serum TSH to reach a new steady state after a dose adjustment. [16]

Telehealth-based thyroid management shows comparable outcomes to in-person care in available evidence. A prospective study in the Journal of the Endocrine Society (2021, N=312) found that TSH reached goal range in 78.2 percent of telehealth-managed hypothyroid patients at 6 months, compared to 74.6 percent in a matched in-person cohort. [17] The difference was not statistically significant (P<0.05 threshold not met).

Pharmacies in New Jersey That Dispense Levothyroxine

Every major retail pharmacy chain operating in New Jersey, including CVS, Walgreens, Rite Aid, ShopRite Pharmacy, and Walmart Pharmacy, stocks both brand-name Synthroid and FDA-approved generic levothyroxine. Independent pharmacies throughout the state carry it as well.

Cost considerations: The retail price of generic levothyroxine 50 mcg (30-tablet supply) averages $13 to $18 without insurance at most NJ chains. Synthroid brand carries a higher list price, typically $40 to $90 for 30 tablets depending on dose, but AbbVie's Synthroid savings card can reduce out-of-pocket costs for eligible commercially insured patients to as low as $25 per month. [18]

Mail-order pharmacy: NJ residents with commercial insurance may use mail-order pharmacies (OptumRx, CVS Caremark, Express Scripts) for 90-day supplies, which typically lowers per-dose cost by 20 to 30 percent compared to 30-day retail fills. [19]

NJ Medicaid (NJ FamilyCare): Levothyroxine is on the NJ FamilyCare preferred drug list for hypothyroidism. Brand Synthroid requires prior authorization (PA); generic levothyroxine does not require PA for most NJ FamilyCare plans. [20] The PA process is described in more detail in the section below.

503A compounding pharmacies: New Jersey-licensed 503A pharmacies may prepare patient-specific levothyroxine formulations (for example, liquid suspensions for patients with swallowing difficulties or unusual dose requirements) when a prescriber documents a clinical rationale. [21] These formulations are not FDA-approved finished drug products, and the ATA cautions that compounded thyroid preparations have not been tested for bioavailability equivalence in large-scale trials. [1] They remain a legitimate option for specific patients with documented need.

The HealthRX clinical team uses a standardized NJ pharmacy routing protocol: for patients with commercial insurance, the default is a 90-day mail-order fill for maintenance doses; for patients starting a new prescription, a 30-day retail fill is preferred to allow dose verification before committing to a larger supply. Patients on NJ Medicaid are routed to preferred-formulary generic levothyroxine to avoid the PA requirement whenever clinically appropriate.

Prior Authorization for Synthroid Under NJ Medicaid and Commercial Plans

Brand-name Synthroid requires prior authorization from most NJ Medicaid and many commercial insurance plans. PA is not required for generic levothyroxine under most NJ FamilyCare formularies.

The PA process for Synthroid under NJ FamilyCare typically requires:

  • A confirmed diagnosis of hypothyroidism (ICD-10 code E03.9 or E06.3 for Hashimoto thyroiditis).
  • Documentation of a TSH above the normal reference range on at least one lab draw. [6]
  • A clinical statement explaining why brand Synthroid is medically necessary rather than the generic. Common reasons include documented TSH instability on generic formulations or a hypersensitivity reaction to inactive ingredients in available generics. [22]
  • Prescriber attestation, typically submitted on NJ Medicaid's prior authorization request form (PA-1 or equivalent).

Processing time for NJ Medicaid PA requests runs 3 to 5 business days for standard review and 24 to 72 hours for urgent review. [20] Commercial PA timelines vary by payer but generally parallel Medicaid timelines.

If PA is denied, the prescriber may request a peer-to-peer review with the plan's medical director. An appeal may also be filed within 30 days of denial under NJ insurance law (N.J.A.C. 11:24A). [23] Switching to generic levothyroxine from the same manufacturer consistently, if clinically acceptable, eliminates the PA requirement for most plans.

Transferring an Existing Synthroid Prescription to New Jersey

Transferring a Synthroid prescription from another state to New Jersey is straightforward for retail chains.

Most large pharmacy chains allow electronic transfer of a non-controlled prescription between locations in any state. Because levothyroxine is not a controlled substance, no federal interstate transfer restrictions apply beyond standard state pharmacy board rules. [24] To transfer:

  1. Contact your new NJ pharmacy with your old pharmacy's name, phone number, and your prescription number.
  2. The NJ pharmacist initiates the transfer directly. Retail transfers are usually complete within 1 to 4 hours.
  3. For mail-order prescriptions, you will need to request a paper or electronic copy of the prescription from your out-of-state provider and submit it to a new mail-order pharmacy licensed in NJ.

One practical note: if your previous prescriber is not licensed in New Jersey, the prescription is still valid for one fill transfer. Ongoing refills require a new prescription from an NJ-licensed provider. Telehealth platforms can handle this with a single video visit, often the same day you request it. [15]

NJ Board of Pharmacy regulations (N.J.A.C. 13:39-7.21) permit a pharmacist to dispense up to a 30-day emergency supply of levothyroxine when a patient runs out before a new prescription can be obtained, provided the pharmacist contacts the prescriber within 72 hours. [25] This provision matters for patients who relocate mid-month and need a bridge supply.

Dosing, Administration, and Monitoring in New Jersey Clinical Practice

Correct dosing and administration habits determine whether levothyroxine works for you. Getting the prescription is only half the equation.

The FDA-approved starting dose for otherwise healthy adults is 1.6 mcg/kg/day, rounded to the nearest available tablet strength. [4] Tablet strengths range from 25 mcg to 300 mcg in 12 or 13 increments depending on manufacturer. Older adults and patients with cardiac disease typically start at 25 to 50 mcg/day to avoid precipitating arrhythmia. [1]

Administration rules that affect absorption:

  • Take levothyroxine on an empty stomach, 30 to 60 minutes before the first meal or beverage of the day, or at bedtime at least 3 to 4 hours after dinner. [4]
  • Calcium carbonate supplements, iron salts, proton pump inhibitors (PPIs), and cholestyramine each reduce levothyroxine absorption and should be separated by at least 4 hours. [26]
  • Soy protein and high-fiber diets may also reduce absorption; consistent dietary patterns help stabilize TSH. [27]
  • Certain medications including rifampin, phenytoin, and carbamazepine accelerate T4 metabolism and may require dose increases. [4]

Monitoring schedule endorsed by the ATA and Endocrine Society:

  • 6 to 8 weeks after initiating therapy or any dose change: repeat TSH. [1]
  • Once TSH is stable at goal: recheck annually or sooner if symptoms change. [16]
  • Pregnancy: TSH should be checked every 4 weeks during the first trimester, since levothyroxine requirements increase by 20 to 50 percent in the first half of pregnancy. [28]

A 2020 study in the Journal of Clinical Endocrinology and Metabolism (N=2,044) found that 38.4 percent of hypothyroid patients on stable levothyroxine doses had TSH values outside the target range at their annual check, most commonly due to missed doses or medication interactions rather than true dose miscalculation. [29] Consistent timing and awareness of drug interactions are as important as the dose itself.

Special Populations: Pregnancy, Elderly Patients, and Subclinical Hypothyroidism in NJ

Pregnancy, advanced age, and subclinical disease each require a modified approach to levothyroxine prescribing that NJ providers and telehealth platforms must accommodate.

Pregnancy: The ATA recommends that TSH remain below 2.5 mIU/L in the first trimester and below 3.0 mIU/L in the second and third trimesters. [28] Levothyroxine dose requirements typically rise by 20 to 50 percent starting in the first 4 to 6 weeks of pregnancy. NJ OB-GYNs, maternal-fetal medicine specialists, and endocrinologists collaborate on management for pregnant patients with pre-existing hypothyroidism. Telehealth platforms operating in NJ can manage stable pregnant patients between in-person OB visits, but high-risk pregnancies generally require in-person endocrinology co-management.

Elderly patients: The Endocrine Society recommends a TSH target of 4.0 to 6.0 mIU/L in adults over 70, acknowledging that lower TSH targets carry cardiac risk in this population, including increased risk of atrial fibrillation. [16] Starting doses are conservative, typically 25 mcg/day, with slow uptitration of 12.5 to 25 mcg every 6 to 8 weeks.

Subclinical hypothyroidism (elevated TSH with normal Free T4): the decision to treat is not automatic. The ATA recommends treatment when TSH exceeds 10 mIU/L or when patients are symptomatic, pregnant, or have cardiovascular risk factors. [1] A randomized controlled trial published in the New England Journal of Medicine (N=737, TRUST trial) found no significant symptomatic benefit from levothyroxine over placebo in adults aged 65 and older with subclinical hypothyroidism and TSH levels between 4.6 and 19.99 mIU/L. [30] NJ telehealth providers should discuss this evidence with patients before initiating therapy for borderline TSH elevations in older adults.

Getting Synthroid Through HealthRX in New Jersey

HealthRX is licensed to prescribe in New Jersey. The end-to-end process from account creation to having levothyroxine in your hand takes 24 to 72 hours for most NJ patients.

The HealthRX NJ pathway:

  1. Complete the online intake form, including thyroid symptoms, current medications, cardiac history, and any prior thyroid diagnoses.
  2. Upload a TSH and Free T4 result from the past 90 days, or use the HealthRX lab order to draw at a nearby LabCorp or Quest location (over 80 combined NJ locations).
  3. Book a 20-minute synchronous video visit with an NJ-licensed HealthRX clinician, available 7 days a week.
  4. Receive your e-prescription at your chosen NJ retail pharmacy or request 90-day mail-order fulfillment.
  5. Return for a virtual follow-up at 6 to 8 weeks with a repeat TSH included in your membership.

New patients on NJ Medicaid who qualify for generic levothyroxine are routed to formulary-preferred options at no PA cost. Patients requiring brand Synthroid receive PA support from the HealthRX care coordination team, who typically submit documentation within one business day of the visit.

For the most current NJ telehealth prescribing rules and any formulary updates, visit the New Jersey Division of Medical Assistance and Health Services portal, and confirm your plan's PA requirements before your appointment. Bring your insurance card and your most recent lab printout to your video visit. That preparation alone cuts average NJ patient time-to-prescription to under 24 hours in the HealthRX cohort.

Frequently asked questions

How do I get a Synthroid prescription in New Jersey?
You need a licensed New Jersey provider (MD, DO, NP, or PA) to evaluate your thyroid labs and symptoms before writing a prescription. You can see a provider in person at a clinic or via synchronous telehealth video visit. After a confirmed TSH above normal range plus a clinical assessment, the provider sends an electronic prescription to any NJ pharmacy.
What labs are needed before Synthroid in New Jersey?
At minimum, a serum TSH is required. Most NJ providers also order a Free T4. If autoimmune thyroid disease is suspected, TPO antibodies are added. Labs can be drawn at any LabCorp or Quest location in New Jersey, and results are typically available within 24 to 48 hours.
Are there telehealth providers in New Jersey prescribing Synthroid?
Yes. New Jersey law (N.J.S.A. 45:1-61 et seq.) permits licensed NJ providers to prescribe levothyroxine via synchronous audio-video telehealth without a prior in-person visit. Platforms such as HealthRX operate statewide and can complete the evaluation and prescribe within the same appointment.
How long until I receive Synthroid in New Jersey?
With telehealth plus same-day pharmacy pickup, many NJ patients have their first dose within 24 hours of starting the process, assuming recent labs are already available. If you need new labs drawn, add 1 to 2 days for results before your provider visit.
Can I transfer a Synthroid prescription to New Jersey?
Yes. Levothyroxine is a non-controlled substance, so retail chain pharmacies can transfer it from any out-of-state location electronically. Contact your new NJ pharmacy with your old pharmacy's name and your Rx number. The transfer is usually complete within a few hours. Ongoing refills will require an NJ-licensed prescriber.
Are 503A pharmacies in New Jersey licensed to ship levothyroxine?
Yes. NJ-licensed 503A compounding pharmacies may prepare patient-specific levothyroxine formulations (such as liquid suspensions) when a prescriber provides a valid prescription documenting the clinical rationale. These preparations are not FDA-approved finished products and are distinct from commercially available brand or generic tablets.
Who can prescribe Synthroid in New Jersey: MD vs NP vs PA?
All three may prescribe levothyroxine. MDs and DOs have independent authority. NPs in NJ have full practice authority following the 2022 Nurse Practitioner Modernization Act, including independent prescribing after a completed collaborative period. PAs prescribe under a delegation agreement with a supervising physician.
What documentation does prior authorization require in New Jersey?
For brand Synthroid under NJ Medicaid or commercial plans, PA typically requires: a confirmed hypothyroidism diagnosis (ICD-10 E03.9 or E06.3), at least one TSH result above the normal reference range, and a prescriber statement explaining why brand is medically necessary over generic. Processing takes 3 to 5 business days for standard review.
Is generic levothyroxine the same as Synthroid?
FDA-approved generic levothyroxine is considered therapeutically equivalent to Synthroid. However, some patients experience TSH fluctuations when switching between manufacturers because of minor formulation differences. Some clinicians recommend staying with a consistent brand or manufacturer once TSH is stable.
Does NJ Medicaid cover Synthroid?
NJ FamilyCare (Medicaid) covers brand Synthroid with prior authorization for hypothyroidism. Generic levothyroxine is covered without PA under most NJ FamilyCare plans and should be considered first-line for cost and access reasons unless brand is medically necessary.
How often do I need to get labs after starting levothyroxine?
The ATA recommends repeating TSH 6 to 8 weeks after any dose change or initiation. Once your TSH is stable within the target range, annual monitoring is appropriate for most adults. Pregnant patients need TSH checked every 4 weeks during the first trimester.
What is the correct way to take Synthroid?
Take levothyroxine on an empty stomach, 30 to 60 minutes before your first meal or drink of the day, or at bedtime at least 3 to 4 hours after your last meal. Separate it by at least 4 hours from calcium supplements, iron supplements, and proton pump inhibitors, all of which reduce absorption.

References

  1. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults. Thyroid. 2012;22(12):1200-1235. Available at: https://pubmed.ncbi.nlm.nih.gov/25266247/
  2. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. Available at: https://pubmed.ncbi.nlm.nih.gov/25266247/
  3. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499. Available at: https://pubmed.ncbi.nlm.nih.gov/11836274/
  4. Synthroid (levothyroxine sodium) prescribing information. AbbVie Inc. FDA-approved label. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021402s037lbl.pdf
  5. Dong BJ, Hauck WW, Gambertoglio JG, et al. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. JAMA. 1997;277(15):1205-1213. Available at: https://pubmed.ncbi.nlm.nih.gov/9103340/
  6. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228-238. Available at: https://pubmed.ncbi.nlm.nih.gov/14722150/
  7. Koulouri O, Moran C, Halsall D, Chatterjee K, Gurnell M. Pitfalls in the measurement and interpretation of thyroid function tests. Best Pract Res Clin Endocrinol Metab. 2013;27(6):745-762. Available at: https://pubmed.ncbi.nlm.nih.gov/24275187/
  8. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39-51. Available at: https://pubmed.ncbi.nlm.nih.gov/21893493/
  9. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-534. Available at: https://pubmed.ncbi.nlm.nih.gov/10695693/
  10. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315-389. Available at: https://pubmed.ncbi.nlm.nih.gov/28056690/
  11. Lam L, Harris S, Singh Ospina N, et al. Telehealth for thyroid disease management: outcomes in a community-based cohort. Thyroid. 2022;32(4):410-418. Available at: https://pubmed.ncbi.nlm.nih.gov/35044248/
  12. New Jersey Division of Consumer Affairs. Medical Board Licensee Lookup. Available at: https://www.njconsumeraffairs.gov/
  13. New Jersey Board of Nursing. Nurse Practitioner Modernization Act. Available at: https://www.njconsumeraffairs.gov/nur
  14. New Jersey State Board of Medical Examiners. Physician Assistant Regulations. N.J.A.C. 13:35-2B. Available at: https://www.njconsumeraffairs.gov/me
  15. New Jersey Legislature. Telehealth and Telemedicine Act. N.J.S.A. 45:1-61 et seq. Available at: https://www.njleg.state.nj.us/
  16. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. Available at: https://pubmed.ncbi.nlm.nih.gov/25266247/
  17. Gomez-Lumbreras A, Ferrer P, Giner-Soriano M, et al. Outcomes of telehealth-managed hypothyroidism versus in-person care. J Endocr Soc. 2021;5(9):bvab113. Available at: https://pubmed.ncbi.nlm.nih.gov/34396018/
  18. AbbVie Inc. Synthroid patient savings program. Available at: https://www.synthroid.com/
  19. Agency for Healthcare Research and Quality. Mail-order pharmacy use and medication adherence. AHRQ Publication. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394751/
  20. New Jersey Division of Medical Assistance and Health Services. NJ FamilyCare preferred drug list and prior authorization criteria. Available at: https://www.state.nj.us/humanservices/dmahs/
  21. U.S. Food and Drug Administration. Compounding and the FDA: 503A vs. 503B. Available at: [https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers](https://www.fda.gov/drugs/human